Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 14.8.2026Sandoz Pharmaceuticals d.d. (SAN-SLO-1)38303Fentanyl Sandoz 100 µg/h matrix transdermálna náplasť (emp tdm 5x100 µg/1 h)18.1.2026O
 14.8.2026Sandoz Pharmaceuticals d.d. (SAN-SLO-1)38299Fentanyl Sandoz 75 µg/h matrix transdermálna náplasť (emp tdm 5x75 µg/1 h)13.1.2026O
 14.8.2026Sandoz Pharmaceuticals d.d. (SAN-SLO-1)7951DAbiraterón Sandoz 1000 mg filmom obalené tablety (tbl flm 30x1000 mg (blis.Al/OPA/Al/PVC))10.8.2026O
 14.8.2026Sandoz GmbH (SAN-A)4610CErelzi 50 mg injekčný roztok v naplnenom pere (sol inj 4x1 ml/50 mg (pero napl.skl.))12.8.2026R
 13.8.2026Neuraxpharm Pharmaceuticals, S.L. (NUH)10916BUCCOLAM 7,5 mg orálny roztok (sol ora 4x1,5 ml/7,5 mg (striek.orálna napln.PP))13.8.2026R
 13.8.2026Fresenius Kabi s.r.o. (FRK-CZ-3)5281CSmofKabiven extra Nitrogen (emu inf 4x1518 ml (vak Biofin))17.8.2026R
 13.8.2026Fresenius Kabi s.r.o. (FRK-CZ-3)37977Water for Injection Fresenius Kabi (lif par 10x500 ml (fľ.LDPE))20.8.2026O
 13.8.2026B.Braun Melsungen AG (BME)34271Glukóza B. Braun 40 % koncentrát na infúzny roztok (con inf 20x10 ml (amp.LDPE-Mini-Plasco connect))13.8.2026O
 13.8.2026Viatris Healthcare Limited (VIM-1)03739EFUDIX (ung 1x20 g (tuba Al))13.8.2026O
 13.8.2026Theramex Ireland Limited (THX)09736Zoely 2,5 mg/1,5 mg filmom obalené tablety (tbl flm 28(24 akt.+4 placebo)x2,5 mg/1,5 mg (blis.PVC/Al))22.3.2021O
 12.8.2026AS GRINDEKS (ASK)3229ESitagliptin/Metformin Grindeks 50 mg/1000 mg filmom obalené tablety (tbl flm 196(2x98)x50 mg/1000 mg (blis.PVC/PVDC/Al-multibal.))1.2.2026Z
 12.8.2026Teva B.V. (TEV-NL-4)51647Valsartan Teva 160 mg (tbl flm 98x160 mg (blis.PVC/PE/PVDC/Al))15.9.2026R
 12.8.2026Teva B.V. (TEV-NL-4)51633Valsartan Teva 80 mg (tbl flm 28x80 mg (blis.PVC/PE/PVDC/Al))15.9.2026R
 12.8.2026TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)21278Atorvastatin Teva Pharma 20 mg (tbl flm 90x20 mg (blis.Al/Al))24.9.2026Z
 12.8.2026Novartis Slovakia s.r.o. (NVL-2)84047Sandimmun Neoral 100 mg/ml (sol por 1x50 ml/5 g (fľ.skl.hnedá))12.8.2026O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)